Androgen Annihilation Strategy Prolongs rPFS in mCRPC ...Middle East

News by : (Medscape) -
Adding apalutamide to standard care significantly slows progression of chemotherapy-naive metastatic castration-resistant prostate cancer, according to the final results of a phase 3 trial. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Androgen Annihilation Strategy Prolongs rPFS in mCRPC )

Also on site :

Most Viewed News
جديد الاخبار